Forbes: Scale is the Real Reason for Big Pharma Mergers

Interesting article from Forbes, which posits that the real reason that big pharma companies are merging is not to shore up their weak pipelines, but to increase their scale in order to increase the likelihood of bringing more products to market, faster, and in more parts of the world. No longer is approval by the U.S. FDA the preeminent goal for any drug, but rather getting approved in many markets as quickly as possible.

--Paul Thomas